Jamie Metzl on The Portal (with host Eric Weinstein) Ep. #029 – The Bio-Hacker will see you now
The PortalKey Moments
Embryo selection, CRISPR, and the ethics of the bioengineering frontier.
Key Insights
Embryo selection with IVF/PGD could dramatically expand parental choice but risks narrowing genetic diversity and enforcing societal biases about desirable traits.
The gene-editing era is accelerating beyond CRISPR to new tools; governance and public dialogue are essential to prevent reckless experiments.
Public storytelling is critical to translating complex biology for non-experts, enabling broader participation in shaping technological futures.
US-China science policy and global collaboration shape the security of biotech, highlighting the need for immunizing researchers against political fear-mongering.
Eugenics language remains a potent societal brake; a balanced framework is needed to navigate normative decisions without repeating historical abuses.
INTRODUCTION TO THE PORTAL COMMUNITY
Eric Weinstein opens with housekeeping and announces the Portal’s new website ericweinstein.org, a mailing list, and a thriving 24/7 community. Portalers contribute by transcribing, annotating, making shorts, graphics, and reading clubs via the portal wiki and forum, and by Discord channels dedicated to reading Roger Penrose’s work. The show emphasizes a community of colleagues who build resources around each episode rather than burden the hosts. The message: the Portal is becoming a wider ecosystem where contributors shape the conversation.
BIOSECURITY IN THE BIOTECH ERA
Jamie Metzl recounts his arc from the National Security Council to warning about the biotech revolution’s security implications. He notes how U.S.-China scientific interdependence began under Deng’s reforms and has grown since, creating tensions around national culture and strategic aims. He argues that the current privacy of science must be immunized against political fear and that the Covid era exposed how social biases can hamper rapid safety responses. He foresees a biotech era in which governance and security are inseparable from discovery.
STORYTELLING AS A CATALYST FOR UNDERSTANDING
Metzl describes storytelling as essential to making complex science accessible and ethically navigable. He cites Horace Judson’s Eight Day of Creation and his own novels Genesis Code and Eternal Sonata as attempts to connect data to a narrative that a broad audience can follow. He sees two-way dialogue between scientists and public storytellers: researchers gain intuition from fiction, while writers translate lab work into societal implications. A robust public conversation, not fearmongering, sustains both scientific progress and public trust.
EMBRYO SELECTION AND GENETIC DISEASES
On embryo selection, they explore using IVF and preimplantation genetic diagnosis to prevent Mendelian diseases. They note the plummeting cost of sequencing and the potential to screen many embryos, expanding parents’ choices far beyond a handful. Yet they also warn about risks: loss of genetic diversity, over-optimizing for health, and the ethical burden of deciding which traits count as 'desirable.' The conversation frames embryo selection as a dramatic shift in family planning and culture.
CRISPR, GENE EDITING, AND THE DAWN OF HUMAN ENGINEERING
They discuss CRISPR and the first gene-edited babies in China, targeting CCR5 and potential longevity effects. They critique the lack of hospital approval and informed consent, and juxtapose alarming headlines with data from UK Biobank suggesting potential lifespan trade-offs. The discussion then broadens to argue that embryo selection and in vitro gametogenesis may prove more consequential than direct editing, given the thousands or millions of embryos with different trade-offs. They stress responsible governance to prevent reckless experimentation.
EUGENICS FEAR, REGULATION, AND A MIDDLE PATH
They tackle eugenics and the slippery slope, arguing that labeling selection as eugenics can be a rhetorical cudgel given past abuses. They advocate for normative criteria in embryo choices—health, viability, and well-being—while acknowledging trade-offs and uncertainty about long-term effects. The panel emphasizes governance, open dialogue, and a measured path between prohibition and unfettered experimentation, aiming to align scientific progress with societal values rather than fear or hype.
LOOKING AHEAD: CULTURE, POLICY, AND RESPONSIBLE INNOVATION
Looking ahead, the hosts argue for a global norms framework, engagement with the DIY bio movement, and a culture that welcomes risk management rather than punitive prohibition. They warn that cheap, powerful tools could be misused in clandestine labs, making proactive dialogue and transparent governance essential. The aim is to enable lifesaving advances while protecting against existential risks, by building a shared language that couples scientific ambition with deep public accountability.
Mentioned in This Episode
●Supplements
●Tools & Products
●Books
●Studies Cited
●People Referenced
Common Questions
Embryo selection during IVF involves creating embryos in vitro, extracting a few cells around day five, sequencing them to identify known disease mutations, and choosing which embryo(s) to implant based on genetic results. Jamie notes this is a near-term mechanism for reducing Mendelian disease incidence and will become more powerful as sequencing costs fall. (Answer begins at 1429)
Topics
Mentioned in this video
Referenced as a model for storytelling about the birth of molecular biology and the value of narrativizing scientific progress.
Explained as the primary near-term mechanism for human genetic engineering through embryo testing and selection.
Referencing an analysis of UK Biobank data used to investigate correlations (e.g., CCR5 disruptions and lifespan or cognitive effects).
Named as one of the drugs under study or use in longevity research to mimic calorie-restriction effects.
Jamie Metzl's book about the genetics revolution, human genetic engineering, and the societal implications discussed throughout the interview.
Jamie Metzl's sci-fi novel about the genetics revolution and life extension, discussed as part of his outreach via fiction.
Described as a gene-editing tool analogous to word-processing: guide RNA points to a locus and a nuclease (e.g., Cas9) makes cuts to delete or insert sequences.
Cited via glow-in-the-dark transgenic rabbits as an example of transgenic modification; GFP originally derived from jellyfish.
The gene targeted in the world's first reported gene-edited babies (attempted change meant to confer HIV resistance); discussed for trade-offs and unintended effects.
Highlighted as a leading geneticist ('living Charles Darwin') and an example of a scientist who reads speculative fiction and turns ideas into experiments.
Jamie Metzl's former boss on the National Security Council, mentioned in his origin story about recognizing overlooked threats and revolutions.
Referenced in the context of a public debate/podcast controversy about group differences and free speech (had Charles Murray on his show).
Referenced as having a public debate with Sam Harris about how to handle 'threatening' scientific data and social consequences.
Cited among interventions and supplements being explored to mimic longevity pathways and improve healthspan.
One of Jamie Metzl's earlier near-term sci-fi novels he wrote to tell stories about the genetics revolution.
Chinese scientist who announced (in 2018) the birth of the first claimed gene-edited babies by attempting to disrupt CCR5; discussed as a controversial harbinger.
Named as one of the top geneticists and a member of the WHO advisory context Jamie participates in regarding genome editing.
Russian scientist mentioned for announcing plans for gene-edited babies, illustrating the global spread of attempts at germline editing.
The controversial book on group differences referenced during discussion of data versus social norms and the Harris/Klein debate.
Mentioned as a future technology that could create large numbers of gametes (eggs) from stem cells, vastly expanding embryo-selection options.
Co-inventor of CRISPR-Cas9; mentioned in the context of public discussion and the democratization of gene-editing tools.
U.S. congressman referenced as having invited Jamie to organize hearings after Jamie's early articles on national security and genetics.
Mentioned as a candidate drug for extending healthspan, part of the longevity interventions Jamie discusses.
More from Eric Weinstein
View all 12 summaries
28 minEric Weinstein on Piers Morgan Uncensored (Used with permission of PMU).
3 minThe Twin Nuclei Problem of Cell & Atom
11 minThoughts on the Science Shutdown.
27 minLynching, Police Brutality, BLM and Defunding the Police: a Contrarian Reality Check.
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free